Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

Non-ischemic Cardiomyopathy clinical trials

4 of 5 indexed Non-ischemic Cardiomyopathy trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Non-ischemic Cardiomyopathy: 5 US clinical trials tracked, 4 recruiting.

Non-ischemic Cardiomyopathy is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is American College of Cardiology, running 1 of these trials.

Enrollment posture brief

Registry condition non-ischemic-cardiomyopathy

OPEN 4 | RECR 80% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Non-ischemic Cardiomyopa (th…80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Non-ischemic Cardiomyopathy

Non-ischemic Cardiomyopathy lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Non-ischemic Cardiomyopathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Non-ischemic Cardiomyopathy is recruiting above its size-band peers.

    4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Non-ischemic Cardiomyopathy research.

    American College of Cardiology accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Non-ischemic Cardiomyopathy enrolment sits around 1,000 participants.

    Median target enrolment is 1,000 among the 5 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. Non-ischemic Cardiomyopathy research leans observational.

    1 interventional and 4 observational studies make up this index (20% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Non-ischemic Cardiomyopathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

OPTIMIZER® Integra CCM-D System (Treatment Arm) Device
1 trials
MRI Diagnostic test
1 trials

US sites by state

Facility locations filed on Non-ischemic Cardiomyopathy trials. A trial with sites in several states counts in each.

Ohio 1 trials
New York 1 trials
Maryland 1 trials
Massachusetts 1 trials
Kentucky 1 trials
Kansas 1 trials
Iowa 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Non-ischemic Cardiomyopathy page

5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Non-ischemic Cardiomyopathy condition card totals 5 registered trials; most-linked intervention OPTIMIZER® Integra CCM-D System (Treatment Arm); top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.